Search research articles
Contact Us
Filters
Showing results (501-510 of 577) with videos related to
Page
of 58
Sort By:
Neurology
|
February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Richard A Nash, George J Hutton, Michael K Racke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
William Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood
|
October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation
Christopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.
Leukemia & Lymphoma
|
July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201
Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
British Journal of Haematology
|
January 6, 2016
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
Philippe Armand, Haesook T Kim, Marie-Michele Sainvil, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 3, 2024
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid
Liam D Aubrey, Natalia Ninkina, Sabine M Ulamec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
Steven M Devine, Kouros Owzar, William Blum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2014
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease
Troy C Lund, Sara S Cathey, Weston P Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 12, 2020
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
Mary Eapen, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Haematologica
|
March 24, 2018
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a <i>KMT2A</i> partial tandem duplication targeted therapy: results of phase 1 study NCI 8485
Alice S Mims, Anjali Mishra, Shelley Orwick, et al.
Page
of 58
Search research articles
Search
Showing results (501-510 of 577) with videos related to
Sort By:
Page
of 58
Neurology
|
February 3, 2017
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Richard A Nash, George J Hutton, Michael K Racke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Dose escalation of lenalidomide in relapsed or refractory acute leukemias
William Blum, Rebecca B Klisovic, Heiko Becker, et al.
Blood
|
October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation
Christopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.
Leukemia & Lymphoma
|
July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201
Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
British Journal of Haematology
|
January 6, 2016
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial
Philippe Armand, Haesook T Kim, Marie-Michele Sainvil, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 3, 2024
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid
Liam D Aubrey, Natalia Ninkina, Sabine M Ulamec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
Steven M Devine, Kouros Owzar, William Blum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2014
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease
Troy C Lund, Sara S Cathey, Weston P Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 12, 2020
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
Mary Eapen, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Haematologica
|
March 24, 2018
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a <i>KMT2A</i> partial tandem duplication targeted therapy: results of phase 1 study NCI 8485
Alice S Mims, Anjali Mishra, Shelley Orwick, et al.
Page
of 58